Adjunctive Pentoxifylline And Tocopherol (PENTO) In The Treatment Of Medication-Related Osteonecrosis Of The Jaw (MRONJ): A Prospective, Randomized Controlled Trial To Evaluate A Novel Non-Surgical Treatment

Grant

Date/time Interval

  • March 16, 2018 - June 30, 2021
  • Total Award Amount

  • 6250.00
  • Direct Costs

  • 6250.00
  • Sponsor Award Id

  • UWSC10580
  • Contributor

  • Anthony Morlandt D.D.S., M.D.   Principal Investigator